In contrast, a lower and non-significant reduction was observed in patients with T2D and CVD for CV death [I 2 = 0.0%, HR 0.97, 95% CI (0.73, 1.28), p = 0.807] and MACE [I 2 = 0.0%, HR 0.82, 95% CI (0.72, 0.93), p = 0.805], and no significant benefit was observed in the T2D and CKD/CVD subgroup for CV death [I 2 = 70.5%, HR 0.79, 95% CI (0.56, 1.11), p = 0.177] and MACE [I 2 = 70.5%, HR 0.76, 95% CI (0.62, 0.92), p = 0.177]
Seizures are not listed as a known adverse effect in the prescribing information for semaglutide, tirzepatide, or liraglutide
I worked with several other dietitians in the past, but Claire was the only one who helped me achieve flexibility and balance in my diet
The broader point Huberman keeps making is worth sitting with: the FDA isnt killing peptides
Food and liquid wash residual medication off the oral mucosa before it can absorb